Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Kinast

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|December 27, 2023
The relation of host genetics to symptomatic hepatitis EVolker Kinast, Daniel Todt
Gut|May 31, 2024
Potential risk of porcine-derived pancreatic enzyme medication for the cross-species transmission of hepatitis E virusNicola Frericks, Volker Kinast, Eike Steinmann
Viruses|May 31, 2019
Hepatitis E Virus Drug DevelopmentVolker Kinast, Thomas L Burkard, Daniel Todt, et al.
Current Opinion in Virology|January 9, 2026
Beyond the liver: the broadened tissue tropism of hepatitis E virusSarah Schlienkamp, Olinda Pinto Veiga, Volker Kinast, et al.
Trends in Microbiology|April 24, 2025
How hepatitis E virus invades hepatocytes: the mystery of viral entryYannick Brüggemann, Nicola Frericks, Emely Richter, et al.
Current Opinion in Virology|October 25, 2022
Hepatitis E virus species barriers: seeking viral and host determinantsVolker Kinast, Mara Klöhn, Maximilian K Nocke, et al.
Journal of Hepatology|April 24, 2026
Renewed Momentum for HCV and HCC researchVolker Kinast, Romain Desert, Ralf Bartenschlager, et al.
Transfusion|September 20, 2022
Hepatitis E virus is effectively inactivated by methylene blue plus light treatmentUte Gravemann, Michael Engelmann, Volker Kinast, et al.
Pathogens (Basel, Switzerland)|August 25, 2019
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib TreatmentBernhard Schlevogt, Volker Kinast, Julia Reusch, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|December 27, 2023
The relation of host genetics to symptomatic hepatitis EVolker Kinast, Daniel Todt
Gut|May 31, 2024
Potential risk of porcine-derived pancreatic enzyme medication for the cross-species transmission of hepatitis E virusNicola Frericks, Volker Kinast, Eike Steinmann
Viruses|May 31, 2019
Hepatitis E Virus Drug DevelopmentVolker Kinast, Thomas L Burkard, Daniel Todt, et al.
Current Opinion in Virology|January 9, 2026
Beyond the liver: the broadened tissue tropism of hepatitis E virusSarah Schlienkamp, Olinda Pinto Veiga, Volker Kinast, et al.
Trends in Microbiology|April 24, 2025
How hepatitis E virus invades hepatocytes: the mystery of viral entryYannick Brüggemann, Nicola Frericks, Emely Richter, et al.
Current Opinion in Virology|October 25, 2022
Hepatitis E virus species barriers: seeking viral and host determinantsVolker Kinast, Mara Klöhn, Maximilian K Nocke, et al.
Journal of Hepatology|April 24, 2026
Renewed Momentum for HCV and HCC researchVolker Kinast, Romain Desert, Ralf Bartenschlager, et al.
Transfusion|September 20, 2022
Hepatitis E virus is effectively inactivated by methylene blue plus light treatmentUte Gravemann, Michael Engelmann, Volker Kinast, et al.
Pathogens (Basel, Switzerland)|August 25, 2019
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib TreatmentBernhard Schlevogt, Volker Kinast, Julia Reusch, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Pageof 3